<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7105050\results\search\disease\results.xml">
  <result pre="Abstract Abstract Background Morbidity, severity, and mortality associated with annual" exact="influenza" post="epidemics are of public health concern. We analyzed surveillance"/>
  <result pre="public health concern. We analyzed surveillance data on hospitalized laboratory-confirmed" exact="influenza" post="cases admitted to intensive care units to identify common"/>
  <result pre="2806 (21%) were fatal. Age ≥40 years and infection with" exact="influenza" post="A virus were associated with fatal outcome. Of 5886"/>
  <result pre="virus infection and/or other immune deficiency, and heart, kidney, and" exact="liver disease" post="were associated with fatal outcome; the risk of death"/>
  <result pre="the risk of death was lower for patients with chronic" exact="lung disease" post="and for pregnant women. Conclusions This study re-emphasises the"/>
  <result pre="pregnant women. Conclusions This study re-emphasises the importance of preventing" exact="influenza" post="in the elderly and tailoring strategies to risk groups"/>
  <result pre="strategies to risk groups with underlying medical conditions. age EU" exact="influenza" post="virus intensive care units underlying medical conditions Funding European"/>
  <result pre="groups at risk [9]. The severity and impact of annual" exact="influenza" post="epidemics are key indicators for assessing both seasonal and"/>
  <result pre="groups [10]. Many studies performed during and after the 2009" exact="influenza" post="pandemic have described risk factors in the context of"/>
  <result pre="pandemic have described risk factors in the context of an" exact="influenza" post="pandemic or seasonal epidemics, but they used different study"/>
  <result pre="or death [11–13]. Previously identified risk factors include increasing age," exact="cardiovascular disease," post="malignancy, immunosuppression, hypertension, neuromuscular disease, diabetes mellitus, chronic lung,"/>
  <result pre="risk factors include increasing age, cardiovascular disease, malignancy, immunosuppression, hypertension," exact="neuromuscular disease," post="diabetes mellitus, chronic lung, liver, or metabolic renal disease"/>
  <result pre="include increasing age, cardiovascular disease, malignancy, immunosuppression, hypertension, neuromuscular disease," exact="diabetes mellitus," post="chronic lung, liver, or metabolic renal disease [14, 15]."/>
  <result pre="not all studies [15–18]. According to European data, infection with" exact="influenza" post="virus A(H1N1)pdm09, older age, immunosuppression, pregnancy, and lung or"/>
  <result pre="influenza virus A(H1N1)pdm09, older age, immunosuppression, pregnancy, and lung or" exact="heart disease" post="are associated with increased risk of fatal outcome of"/>
  <result pre="disease are associated with increased risk of fatal outcome of" exact="influenza" post="[11, 16]. The European Centre for Disease Prevention and"/>
  <result pre="Prevention and Control (ECDC) has conducted hospital-based surveillance of severe" exact="influenza" post="since the pandemic in 2009 [19]. Aggregate data are"/>
  <result pre="in 2009 [19]. Aggregate data are published weekly during the" exact="influenza" post="season [6], but case-based data have not been systematically"/>
  <result pre="21]. Therefore, our aim was to analyze data on laboratory-confirmed" exact="influenza" post="cases admitted to ICUs to identify common determinants of"/>
  <result pre="and help target prevention strategies. METHODS Data Source During each" exact="influenza" post="surveillance season, ECDC collects weekly case-based data on hospitalized"/>
  <result pre="surveillance season, ECDC collects weekly case-based data on hospitalized laboratory-confirmed" exact="influenza" post="cases admitted to ICU from a number of European"/>
  <result pre="Reported information on laboratory-confirmed cases in ICUs included the following:" exact="influenza" post="virus type; subtype (A(H1N1)pdm09, A(H3N2)) and lineage (B/Victoria, B/Yamagata);"/>
  <result pre="conditions were reported: asthma, cancer, chronic heart, kidney, liver or" exact="lung disease," post="diabetes, human immunodeficiency virus (HIV)/other immune deficiency, neurocognitive and"/>
  <result pre="acquired conditions as well as infectious diseases such as tuberculosis," exact="hepatitis" post="B or C, etc. Asthma and lung disease were"/>
  <result pre="such as tuberculosis, hepatitis B or C, etc. Asthma and" exact="lung disease" post="were pooled as chronic lung condition. Morbid obesity and"/>
  <result pre="and lung disease were pooled as chronic lung condition. Morbid" exact="obesity" post="and obesity were pooled because analyzing them separately did"/>
  <result pre="disease were pooled as chronic lung condition. Morbid obesity and" exact="obesity" post="were pooled because analyzing them separately did not show"/>
  <result pre="type, and fatal outcome. Inclusion criteria were as follows: laboratory-confirmed" exact="influenza" post="cases admitted to ICU, influenza virus type A or"/>
  <result pre="criteria were as follows: laboratory-confirmed influenza cases admitted to ICU," exact="influenza" post="virus type A or B confirmation, known age, sex,"/>
  <result pre="subset of the basic dataset that included cases with known" exact="influenza" post="A virus subtype (or B type) and underlying condition(s)"/>
  <result pre="basic dataset that included cases with known underlying conditions and" exact="influenza" post="A virus subtype (A(H3N2) or A(H1N1)pdm09) or B type."/>
  <result pre="respectively). Of the 13 368 patients in ICU with laboratory-confirmed" exact="influenza" post="virus infection, 2806 (21%) died (Table 1). The majority"/>
  <result pre="intensive care unit; Ref., Reference. aAdjusted for reporting country. Most" exact="influenza" post="viruses (11 809; 88%) were type A: 5223 (44%)"/>
  <result pre="were reported without subtype. In all seasons, there were more" exact="influenza" post="A viruses (&amp;gt;60% of viruses) compared with B viruses"/>
  <result pre="higher than in seasons with A(H1N1)pdm09 dominance. The proportion of" exact="influenza" post="B virus cases was greater than 20% in both"/>
  <result pre="days (range, 0–198 days) and did not significantly differ between" exact="influenza" post="virus types (P = .1). However, the median stay"/>
  <result pre="Underlying Conditions and Virus Type/Subtype Among 5886 cases with known" exact="influenza" post="virus type and A subtype (A(H1N1)pdm09 and A(H3N2)) and"/>
  <result pre="the patients. The most commonly reported underlying conditions were chronic" exact="lung disease" post="(18%) and obesity (15%). Influenza virus A(H1N1)pdm09 was detected"/>
  <result pre="commonly reported underlying conditions were chronic lung disease (18%) and" exact="obesity" post="(15%). Influenza virus A(H1N1)pdm09 was detected in the majority"/>
  <result pre="cases. The most commonly reported complications were ARDS (51%) and" exact="pneumonia" post="(41%). Acute respiratory distress syndrome (IRR, 1.02; 95% CI,"/>
  <result pre="(41%). Acute respiratory distress syndrome (IRR, 1.02; 95% CI, 0.92–1.13)," exact="encephalitis" post="(IRR, 1.16; 95% CI, 0.78–1.70), and pneumonia (IRR, 0.91;"/>
  <result pre="95% CI, 0.92–1.13), encephalitis (IRR, 1.16; 95% CI, 0.78–1.70), and" exact="pneumonia" post="(IRR, 0.91; 95% CI, 0.82–1.02) were not associated with"/>
  <result pre="adjusting for reporting country, age, and sex. Although sepsis and" exact="myocarditis" post="were reported only for 6% and less than 2%"/>
  <result pre="conditions such as HIV/immunosuppression (IRR, 2.11; 95% CI, 1.48–3.03) or" exact="heart disease" post="(IRR, 1.81; 95% CI, 1.12–2.91) increased the risk to"/>
  <result pre="the basic model including cases with known gender, age, and" exact="influenza" post="virus type, the determinants associated with fatal outcome in"/>
  <result pre="sex, age of 40 years and older, and infection with" exact="influenza" post="A virus (Table 1). The risk for fatal outcome"/>
  <result pre="1.01–1.02), using age as continuous variable. In the multivariable model," exact="influenza" post="A virus infection and older age (≥40 years) were"/>
  <result pre="older. The univariable analysis of cases with detailed information about" exact="influenza" post="A virus subtype and underlying conditions again identified being"/>
  <result pre="fatal outcome, whereas patients of younger age and with chronic" exact="lung disease" post="were less likely to die. In the multivariable model,"/>
  <result pre="age 60 years and older, cancer, chronic heart, kidney, and" exact="liver disease," post="as well as HIV infection/other immune deficiency and other"/>
  <result pre="mode. Discussion This is the first published analysis of confirmed" exact="influenza" post="ICU cases reported from 12 EU countries over 8"/>
  <result pre="determinants relevant for increased risk of fatal outcome due to" exact="influenza" post="in Europe. The identified limitations of reporting and pooling"/>
  <result pre="The results showed an increasing risk of death associated with" exact="influenza" post="A and increasing age over 40 years, which partly"/>
  <result pre="have also been shown to be less likely tested for" exact="influenza" post="virus infection in the hospital setting [30]. The data"/>
  <result pre="[30]. The data reported to TESSy were not complete regarding" exact="influenza" post="virus A subtype and B lineage as well as"/>
  <result pre="to missing virus subtype information. The high proportion of unsubtyped" exact="influenza" post="A viruses, ranging from 0.1% during the pandemic season"/>
  <result pre="the analysis. We also observed that the proportion of unsubtyped" exact="influenza" post="A viruses was higher in A(H3N2)-predominant seasons than in"/>
  <result pre="2009 pandemic continue to be used in diagnostics, so if" exact="influenza" post="A viruses test negative in the specific A(H1N1)pdm09 test,"/>
  <result pre="subtype-specific analyses. Another reason could be an increased testing for" exact="influenza" post="A and B in acute hospital settings using point-of-care"/>
  <result pre="regarding vaccine effectiveness. In a French study, female sex and" exact="influenza" post="vaccination were described as protective factors with regard to"/>
  <result pre="findings that HIV infection/other immune deficiency, cancer, heart, kidney, and" exact="liver disease" post="increase the likelihood of fatal outcomes as do increasing"/>
  <result pre="fatal outcomes as do increasing age over 40 years and" exact="influenza" post="A infection [14, 15, 31]. All EU/EEA Member States"/>
  <result pre="infection [14, 15, 31]. All EU/EEA Member States recommend annual" exact="influenza" post="vaccination for persons 65 years of age and older."/>
  <result pre="disease, immunosuppression, metabolic disorders, HIV/acquired immune deficiency syndrome, and morbid" exact="obesity" post="[32, 33]. Our analysis showed that HIV infection/other immunosuppressive"/>
  <result pre="are known to be at greater risk of dying from" exact="influenza" post="and its complications due to their susceptibility to infection,"/>
  <result pre="over 500 000 estimated people with HIV in EU/EEA countries," exact="influenza" post="vaccines as well as early antiviral treatment should be"/>
  <result pre="an association between pre-existing lung, neuromuscular or neurocognitive disease, or" exact="obesity" post="and fatal outcome in hospitalized patients; however, this was"/>
  <result pre="analysis [14, 15]. In our study, chronic lung condition including" exact="asthma" post="was not associated with an increased risk of death"/>
  <result pre="nonasthmatics [40]. Pregnancy is considered a risk factor for severe" exact="influenza" post="[11], and a large majority of EU/EEA Member States"/>
  <result pre="[11], and a large majority of EU/EEA Member States recommended" exact="influenza" post="vaccination for pregnant women [32, 33]. Although approximately 3%"/>
  <result pre="ICU and confirm findings of others [15, 31]. Pregnancy, chronic" exact="lung disease," post="and obesity may increase the risk for hospitalization and"/>
  <result pre="findings of others [15, 31]. Pregnancy, chronic lung disease, and" exact="obesity" post="may increase the risk for hospitalization and ICU admission,"/>
  <result pre="fatal outcomes. Conclusions This study highlights the importance of preventing" exact="influenza" post="virus infection, particularly in the elderly, but also in"/>
  <result pre="(WHO) Regional Office for Europe for our joint collaboration on" exact="influenza" post="surveillance. We thank all clinicians and experts involved in"/>
  <result pre="contributed to this work on behalf of the Dutch SARI" exact="influenza" post="surveillance partners. We are grateful for the review and"/>
  <result pre="KatzM, et al.Global burden of respiratory infections due to seasonal" exact="influenza" post="in young children: a systematic review and meta-analysis. Lancet2011;"/>
  <result pre="meta-analysis. Lancet2011; 378:1917–30.22078723 2.FinebergHVPandemic preparedness and response–lessons from the H1N1" exact="influenza" post="of 2009. N Engl J Med2014; 370:1335–42.24693893 3.HaywardAC, FragaszyEB,"/>
  <result pre="HutubessyRA systematic review of the social and economic burden of" exact="influenza" post="in low- and middle-income countries. Vaccine2015; 33:6537–44.26597032 5.IulianoAD, RoguskiKM,"/>
  <result pre="mortality: a modelling study. Lancet2018; 391:1285–300.29248255 6.SnackenR, BrownCNew developments of" exact="influenza" post="surveillance in Europe. EuroSurveill2015; 20 Available at: https://www.eurosurveillance.org/content/10.2807/ese.20.04.21020-en 7.DunningJ,"/>
  <result pre="for severe influenza. Lancet Infect Dis2014; 14:1259–70.25213733 8.HaydenFG, de JongMDEmerging" exact="influenza" post="antiviral resistance threats. J Infect Dis2011; 203:6–10.21148489 9.collab: World"/>
  <result pre="10.collab: European Centre for Disease Prevention and Control (ECDC). Seasonal" exact="influenza" post="vaccination in Europe; Vaccination recommendations and coverage rates in"/>
  <result pre="and coverage rates in the EU Member States for eight" exact="influenza" post="seasons, 2007–2008 to 2014–2015. Stockholm: ECDC; 2017. 11.MeerhoffTJ, SimakuA,"/>
  <result pre="JiW, GuoZ, et al.Risk factors and outcomes for pandemic H1N1" exact="influenza" post="compared with seasonal influenza in hospitalized children in China."/>
  <result pre="factors and outcomes for pandemic H1N1 influenza compared with seasonal" exact="influenza" post="in hospitalized children in China. Can J Infect Dis"/>
  <result pre="for Severe H1N1pdm InfectionRisk factors for severe outcomes following 2009" exact="influenza" post="A (H1N1) infection: a global pooled analysis. PLoS Med2011;"/>
  <result pre="KimTH, JohnstoneJ, et al.Populations at risk for severe or complicated" exact="influenza" post="illness: systematic review and meta-analysis. BMJ2013; 347:f5061.23974637 16.BonmarinI, BelchiorE,"/>
  <result pre="347:f5061.23974637 16.BonmarinI, BelchiorE, BergouniouxJ, et al.Intensive care unit surveillance of" exact="influenza" post="infection in France: the 2009/10 pandemic and the three"/>
  <result pre="17.KarlssonEA, MarcelinG, WebbyRJ, Schultz-CherrySReview on the impact of pregnancy and" exact="obesity" post="on influenza virus infection. Influenza Other Respir Viruses2012; 6:449–60.22335790"/>
  <result pre="WebbyRJ, Schultz-CherrySReview on the impact of pregnancy and obesity on" exact="influenza" post="virus infection. Influenza Other Respir Viruses2012; 6:449–60.22335790 18.SkowronskiDM, De"/>
  <result pre="infection. Influenza Other Respir Viruses2012; 6:449–60.22335790 18.SkowronskiDM, De SerresGIs routine" exact="influenza" post="immunization warranted in early pregnancy?Vaccine2009; 27:4754–70.19515466 19.collab: European Centre"/>
  <result pre="for Disease Prevention and Control.Flu News Europe Joint ECDC-WHO/Europe weekly" exact="influenza" post="update, System description. Available at: http://flunewseurope.org/system. Accessed 6 March"/>
  <result pre="27.SnackenR, QuintenC, DevauxI, et al.Surveillance of hospitalised severe cases of" exact="influenza" post="A(H1N1)pdm09 and related fatalities in nine EU countries in"/>
  <result pre="2009 A/H1N1 pandemic in the US and comparison with past" exact="influenza" post="seasons. PLoS Curr.2010; 2:RRN1153.20352125 30.HartmanL, ZhuY, EdwardsKM, et al.Underdiagnosis"/>
  <result pre="seasons. PLoS Curr.2010; 2:RRN1153.20352125 30.HartmanL, ZhuY, EdwardsKM, et al.Underdiagnosis of" exact="influenza" post="virus infection in hospitalized older adults. J Am Geriatr"/>
  <result pre="31.ColemanBL, FadelSA, FitzpatrickT, ThomasSMRisk factors for serious outcomes associated with" exact="influenza" post="illness in high- versus low- and middle-income countries: Systematic"/>
  <result pre="12:22–9.29197154 32.collab: European Centre for Disease Prevention and Control (ECDC).Seasonal" exact="influenza" post="vaccination in Europe, Overview of vaccination recommendations and coverage"/>
  <result pre="coverage rates in the EU Member States for the 2012–13" exact="influenza" post="season. Technical Report Available at: https://www.ecdc.europa.eu/en/publications-data/seasonal-influenza-vaccination-europe-vaccination-recommendations-and-coverage Accessed 7 July"/>
  <result pre="2016. 33.collab: European Centre for Disease Prevention and Control (ECDC).Seasonal" exact="influenza" post="vaccination and antiviral use in Europe, Overview of vaccination"/>
  <result pre="in the EU Member States for the 2013–14 and 2014–15" exact="influenza" post="seasons. Technical Report. Available at: http://ecdc.europa.eu/en/publications/Publications/Seasonal-influenza-vaccination-antiviral-use-europe.pdf. Accessed 15 July"/>
  <result pre="VidaurL, et al.; collab: H1N1 SEMICYUC/REIPI/CIBERES Working groupPandemic and post-pandemic" exact="influenza" post="A (H1N1) infection in critically ill patients. Crit Care2011;"/>
  <result pre="Clinical Information Network FLU-CINDifferences between asthmatics and nonasthmatics hospitalised with" exact="influenza" post="A infection. Eur Respir J2013; 41:824–31.22903963 41.collab: European Centre"/>
 </snippets>
</snippetsTree>
